Oncothyreon Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 89   

Articles published

ONTY 3.41 -0.13 (-3.67%)
price chart
Biotech Stocks: Here's Where to Get In: Oncothyreon Inc (USA) (NASDAQ:ONTY ...
On the trading floor, shares of Oncothyreon Inc (USA) (NASDAQ:ONTY) gained 6.77% to close at $3.31. The $292.02M company on May 30, 2015 announced the presentation of positive data from the company's ongoing trials of ONT-380, an orally active, ...
Company Update (NASDAQ:ONTY): Oncothyreon Inc (USA) Reports Second Quarter ...
Net loss for the three months ended June 30, 2015 was $10.9 million, or $0.11 per basic and diluted share, compared with a net loss of $6.0 million, or $0.09 per basic and diluted share, for the comparable period in 2014.
Oncothyreon Inc.: Oncothyreon Reports Second Quarter 2015 Financial Results  The Wall Street Transcript
Oncothyreon Reports Second Quarter 2015 Financial Results  Nasdaq
Takeways from ASCO 2015: Innate Pharma SA, Oncothyreon Inc (USA), and Affimed NV
Oncothyreon Inc (USA) (NASDAQ:ONTY) continues to be the biggest benefactor of ASCO this year, now up over 200% since investors had a first glimpse at abstracts from the conference.
Why Shares of Oncothyreon Inc. Shot Up Today  Motley Fool
Oncothyreon (ONTY) Stock | When Will We See A Breakout?  CNA Finance (press release)
HC Wainwright Offers Updates on Oncothyreon Inc (USA) (ONTY), Ariad ...
H.C. Wainright analyst Reni Benjamin attended several presentations and offered highlights on Oncothyreon Inc (USA) (NASDAQ:ONTY), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), and Agenus Inc (NASDAQ:AGEN).
Biotech Stocks Buzz: Oncothyreon Inc (USA) (NASDAQ:ONTY), Vertex ...
Investors have been flocking to biotech stocks this year, with the IBB, the ETF that tracks biotech stocks, making noteworthy gains.
Biotech Beat: Oncothyreon Inc (USA), Innate Pharma SA, Regeneron ...
ASCO came to a close early this week, and Oncothyreon Inc (USA) (NASDAQ:ONTY) was this year's undisputed winner among biotech stocks, gaining 185% between May 13 (when abstracts from the conference were released) and the end of this week.
Here's Why Oncothyreon Inc (USA) Shares Are Fully Valued: Cantor
Oncothyreon Inc (USA) (NASDAQ:ONTY) shares have taken off, adding 24.56% to trade at $4.26, after the biotechnology company presented positive study data for its breast cancer treatment at the American Society of Clinical Oncology 2015 meeting.
Here Is Why Oncothyreon Inc (ONTY) Stock Is Trading Up By 31%
The biopharmaceutical company, Oncothyreon Inc (USA) (NASDAQ:ONTY) stock soared 31.19%, and experienced approximately 18 times increment in its trading volume as of 12:02 PM EDT.
Oncothyreon (ONTY) Stock Is Climbing | Can It Last?  CNA Finance (press release)
Active Biotech Stock News - Oncothyreon Inc (USA) (NASDAQ:ONTY), Agenus Inc ...
Oncothyreon Inc (USA) (NASDAQ:ONTY) declined-5.36% to end last trading session at $3.00. The company, on August 06, 2015, reported financial results for the second quarter ended June 30, 2015.
Today's Best Biotech Stocks: Oncothyreon Inc (USA) (NASDAQ:ONTY), Exelixis ...
Oncothyreon Inc (USA) (NASDAQ:ONTY) grew more than 50% in pre-market trading on Monday after declaring that the experimental breast cancer drug ONT-380 was effective and different from other therapies used to treat women with HER2-positive ...